依达拉奉联合尤瑞克林治疗大面积脑梗死疗效观察

Effect of Edaravone Combined Urinary Kallidinogenase on Massive Cerebral Infarction

目的探讨尤瑞克林联合依达拉奉治疗大面积脑梗死的效果。方法随机将60例大面积脑梗死患者平均分为两组,对照组行依达拉奉治疗,观察组在对照组基础上联合尤瑞克林治疗,比较两组临床疗效。结果观察组神经功能缺损程度评分、总有效率均优于对照组(P<0.05)。结论尤瑞克林联合依达拉奉治疗大面积脑梗死效果理想。

Objective To explore the effect of edaravone combined urinary kallidinogenase on patients with massive cerebral infarction. Methods We divided 70 patients into two groups,control group used edaravone treatment,and observation group used urinary kallidinogenase on the basis of control group,comparing efficacy of two groups. Results The NIHSS score and total effective rate of observation group were significantly better than control group（P〈0.05）. Conclusion The effect of edaravone combined urinary kallidinogenase is ideal.